Wall Street Sees a 41% Upside to Select Medical Holdings (SEM)

Group 1 - Select Medical Holdings Corporation (NYSE:SEM) is recognized as one of the best dividend stocks to buy, with an average price target suggesting a 34% upside and a Street high indicating a 41% upside [1][2] - The company reported Q3 2025 results with revenue reaching $1,363.4 million, reflecting a year-over-year increase of 7.2%. Revenue growth was noted in critical illness recovery hospitals (4.6%), rehabilitation hospitals (16.2%), and outpatient rehabilitation segments (4.3%) [2] - A cash dividend of $0.0625 per share was paid on November 25, indicating the company's commitment to returning value to shareholders [2] Group 2 - The board announced a share repurchase initiative with a capacity of up to $1 billion, extending the program's duration to December 31, 2027 [3] - For FY2025, Select Medical estimates total revenue between $5.3 billion and $5.5 billion, with Adjusted EBITDA projected between $510 million and $530 million, and diluted EPS expected to range from $1.14 to $1.24 [3] - Select Medical operates hospitals and outpatient clinics across the U.S., specializing in various medical conditions including heart and lung issues, neurological and orthopedic problems, cancer, work-related injuries, pediatric care, and sports rehabilitation [4]